文献速递基础与转化研究新药、器械与细胞基因治疗研发

瘤内注射细胞因子锚定胶原可安全增强系统性癌症免疫治疗

Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy.
PubMed 文献 · Sci Transl Med · 2019-01-01

细胞因子疗法因严重不良反应和疗效不足而临床应用受限,瘤内注射虽可局部定位但可溶性细胞因子会快速逃逸。研究发现,将与胶原结合蛋白lumican融合的细胞因子瘤内注射可延长局部滞留并显著减少全身暴露;在同系肿瘤模型和BrafV600E/Ptenfl/fl基因工程黑色素瘤模型中,局部给予lumican-细胞因子融合物联合系统性免疫治疗(靶向肿瘤抗体、检查点阻断、癌症疫苗或T细胞疗法)可提高疗效而不加重毒性。局部治疗还诱导了保护性系统性CD8+ T细胞反应,对未注射细胞因子的肿瘤产生治愈性远隔效应。

要点

  • 瘤内注射lumican-细胞因子融合物可延长局部滞留并显著减少全身暴露。
  • 联合系统性免疫治疗可提高疗效而不加重毒性。
  • 局部治疗诱导保护性系统性CD8+ T细胞反应,产生远隔效应。

核心结论

  • 细胞因子胶原锚定是一种简便、不依赖肿瘤类型的策略,可安全增强原本疗效有限的系统性免疫治疗。

研究设计与样本

  • 研究在同系肿瘤模型和BrafV600E/Ptenfl/fl基因工程黑色素瘤模型中进行。

主要发现

  • 瘤内注射与胶原结合蛋白lumican融合的细胞因子可延长局部滞留并显著减少全身暴露。
  • 局部给予lumican-细胞因子融合物联合系统性免疫治疗(靶向肿瘤抗体、检查点阻断、癌症疫苗或T细胞疗法)可提高疗效而不加重毒性。
  • 局部治疗诱导保护性系统性CD8+ T细胞反应,对未注射细胞因子的肿瘤产生治愈性远隔效应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The clinical application of cytokine therapies for cancer treatment remains limited due to severe adverse reactions and insufficient therapeutic effects. Although cytokine localization by intratumoral administration could address both issues, the rapid escape of soluble cytokines from the tumor invariably subverts this effort. We find that intratumoral administration of a cytokine fused to the collagen-binding protein lumican prolongs local retention and markedly reduces systemic exposure. Combining local administration of lumican-cytokine fusions with systemic immunotherapies (tumor-targeting antibody, checkpoint blockade, cancer vaccine, or T cell therapy) improves efficacy without exacerbating toxicity in syngeneic tumor models and the BrafV600E /Ptenfl/fl genetically engineered melanoma model. Curative abscopal effects on noncytokine-injected tumors were also observed as a result of a protective and systemic CD8+ T cell response primed by local therapy. Cytokine collagen-anchoring constitutes a facile, tumor-agnostic strategy to safely potentiate otherwise marginally effective systemic immunotherapies.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Momin N, Mehta NK, Bennett NR, et al. Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy. Sci Transl Med. 2019. PMID: 31243150. doi:10.1126/scitranslmed.aaw2614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。